Literature DB >> 19828378

Fetal-maternal exchange of multipotent stem/progenitor cells: microchimerism in diagnosis and disease.

Thomas Klonisch1, Régen Drouin.   

Abstract

The biological concept of microchimerism, the bidirectional trafficking and stable long-term persistence of small numbers of allogeneic (fetal and maternal) cells in a genetically different organ, has gained considerable attention. Microchimerism is a common phenomenon in many species, including humans, and microchimeric cells can modify immunological recognition or tolerance, affect the course and outcome of various diseases and demonstrate stem cell-like or regenerative potential. Here, we review current knowledge of the biology of microchimerism and show how long-term allogeneic co-existence within an organism can impact on existing paradigms in chronic disease, cancer biology, regenerative medicine and fetal-maternal immunology. We discuss diagnostic challenges, clinical applications and future research directions in this exciting and rapidly emerging field of allogeneic fetal-maternal cell exchange.

Entities:  

Mesh:

Year:  2009        PMID: 19828378     DOI: 10.1016/j.molmed.2009.09.002

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  21 in total

1.  Verification of the genomic identity of candidate microchimeric cells.

Authors:  Peter Sedlmayr; Thomas Kroneis
Journal:  Chimerism       Date:  2011-07-01

Review 2.  Fetal microchimerism as an explanation of disease.

Authors:  Laura Fugazzola; Valentina Cirello; Paolo Beck-Peccoz
Journal:  Nat Rev Endocrinol       Date:  2010-12-21       Impact factor: 43.330

3.  Fetal cells traffic to injured maternal myocardium and undergo cardiac differentiation.

Authors:  Rina J Kara; Paola Bolli; Ioannis Karakikes; Iwao Matsunaga; Joseph Tripodi; Omar Tanweer; Perry Altman; Neil S Shachter; Austin Nakano; Vesna Najfeld; Hina W Chaudhry
Journal:  Circ Res       Date:  2011-11-14       Impact factor: 17.367

4.  Indirect evidence that maternal microchimerism in cord blood mediates a graft-versus-leukemia effect in cord blood transplantation.

Authors:  Jon J van Rood; Andromachi Scaradavou; Cladd E Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-09       Impact factor: 11.205

5.  The role of fetal microchimerism in autoimmune disease.

Authors:  Ralph P Miech
Journal:  Int J Clin Exp Med       Date:  2010-06-12

6.  Long-term feto-maternal microchimerism revisited: Microchimerism and tolerance in hematopoietic stem cell transplantation.

Authors:  Tatsuo Ichinohe
Journal:  Chimerism       Date:  2010 Jul-Sep

Review 7.  Clinical review: The emerging cell biology of thyroid stem cells.

Authors:  Terry F Davies; Rauf Latif; Noga C Minsky; Risheng Ma
Journal:  J Clin Endocrinol Metab       Date:  2011-07-21       Impact factor: 5.958

8.  A Child's HLA-DRB1 genotype increases maternal risk of systemic lupus erythematosus.

Authors:  Giovanna I Cruz; Xiaorong Shao; Hong Quach; Kimberly A Ho; Kirsten Sterba; Janelle A Noble; Nikolaos A Patsopoulos; Michael P Busch; Darrell J Triulzi; Wendy S W Wong; Benjamin D Solomon; John E Niederhuber; Lindsey A Criswell; Lisa F Barcellos
Journal:  J Autoimmun       Date:  2016-07-04       Impact factor: 7.094

Review 9.  Stem cells and neuroprotection: understanding the players.

Authors:  Virginia Pearce
Journal:  Int J Mol Sci       Date:  2010-09-15       Impact factor: 5.923

10.  Pregnancy and the risk of autoimmune disease.

Authors:  Ali S Khashan; Louise C Kenny; Thomas M Laursen; Uzma Mahmood; Preben B Mortensen; Tine B Henriksen; Keelin O'Donoghue
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.